Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
861 4 |
Ultima descărcare din IBN: 2022-03-28 23:44 |
SM ISO690:2012 ROMANCIUC, Lilia, REVENCO, Ninel. Influenţa betablocantului bisoprolol asupra simptomatologiei clinice la copiii cu prolaps de valvă mitrală. In: Analele Ştiinţifice ale USMF „N. Testemiţanu”, 2011, nr. 5(12), pp. 236-240. ISSN 1857-1719. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Analele Ştiinţifice ale USMF „N. Testemiţanu” | ||||||
Numărul 5(12) / 2011 / ISSN 1857-1719 | ||||||
|
||||||
Pag. 236-240 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
The influence of beta – bloker (bisoprolol) on clinical symptoms
in children with mitral valve prolapse
The carried out research has included 50 children, with mitral valve prolapse I and II
degree, at the age from 7 till 18 years: I group (bisoprolol) 30 (60,0 %) children, average age
(12,90±0,53) years and II group (placebo) 20 (40,0 %) children, average age (13,5±0,60) years,
doses of bisoprolol (PO): 1,25-2,5mg/kg/dose with inspection of clinical symptoms .
Results of research have revealed, that syndrome of mitral valve prolapse is accompanied
by various clinical symptoms with prevalence of heart pain (90%) and palpitations in 88,0%
cases. Results of research have revealed, that in children with symptomatic mitral valve prolapse,
bisoprolol has considerably reduced heart pain and palpitations (p <0,001) in comparison with
placebo. Bisoprolol can be recommended as treatment in children with symptomatic mitral valve
prolapse as it possesses high cardioselectivity (1:75) index. |
||||||
|